Back to Journals » Risk Management and Healthcare Policy » Volume 18
Exploring Health-Related Quality of Life and Correlates Among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers in Aljouf Province, Saudi Arabia: A Multi-Site Cross-Sectional Study
Authors Alsaidan AA , Alshehri AA, Thirunavukkarasu A, Alsaidan OA , Alhassan HH, Morad MH, Alshehari A , Alibrahim A
Received 26 December 2024
Accepted for publication 10 June 2025
Published 18 June 2025 Volume 2025:18 Pages 2007—2020
DOI https://doi.org/10.2147/RMHP.S514414
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jongwha Chang
Aseel Awad Alsaidan,1 Abdulmajeed Ali Alshehri,1 Ashokkumar Thirunavukkarasu,1 Omar Awad Alsaidan,2 Hassan H Alhassan,3 Muaid Hashem Morad,4 Abdullah Alshehari,5 Alaa Alibrahim6
1Department of Family and Community Medicine, College of Medicine, Jouf University, Sakaka, Aljouf, Saudi Arabia; 2Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia; 3Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Aljouf, Saudi Arabia; 4Department of Internal Medicine, College of Medicine, Al-Baha university, Al-Baha, Saudi Arabia; 5Department of Quality and Patient Safety, Khamis Mushayte Hospital, Aseer, Saudi Arabia; 6Department of Internal Medicine, College of medicine, Jouf university, Aljouf, Saudi Arabia
Correspondence: Aseel Awad Alsaidan, Department of Family and Community Medicine, College of Medicine, Jouf University, Sakaka, 72388, Saudi Arabia, Tel +966-506065757, Email [email protected]
Purpose: Type 2 diabetes mellitus (T2DM) impacts various elements of health-related quality of life (HRQoL). However, research on the HRQoL of T2DM patients in primary healthcare settings in Saudi Arabia is limited. Therefore, we aimed to determine the HRQoL and associated factors among patients with T2DM to plan policy-driven interventions and improve patient outcomes.
Participants and Methods: We surveyed 390 patients with T2DM attending primary health centers (PHCs) in the Aljouf province of Saudi Arabia. We included Saudi adults (≥ 18 years) diagnosed at least six months before the study and completed at least one follow-up visit at the PHC. In the present cross-sectional study, we used the validated 20-item short-form health survey (SF-20)-Arabic tool to assess different HRQoL domains. We performed Mann–Whitney U and Kruskal–Wallis tests for dichotomous and categorical variables, respectively, in each domain. Finally, a binomial logistic regression analysis was performed to determine the predictors of overall HRQoL.
Results: The role functioning domain had the highest mean score (75.7± 19.7), and the lowest scores were in the social functioning (47.9± 20.2) and pain domains (48.9± 21.4). Some characteristics, such as marital status, treatment type, and follow-up adherence, were significantly associated with most domains. HRQoL was significantly higher in male patients (p=0.002, adjusted odds ratio [AOR]=2.66) and those on oral hypoglycemic agents (OHAs; p=0.002, AOR=5.18). Obese patients had a significantly lower HRQoL (p=0.036, AOR=0.058). These factors remained significant after adjusting for age, sex, body mass index, treatment type, and comorbidities in the multivariate analysis.
Conclusion: We recommend policy changes that incorporate interventions tailored to improve HRQoL, especially in social functioning and pain domains. Moreover, integrating comprehensive pain management strategies and enhancing patient follow-up within PHCs may improve quality of life, especially for high-risk patients with T2DM.
Keywords: diabetes mellitus, primary healthcare, quality of life, T2DM patients, SF-20, pain management
Introduction
Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), is a critical global health problem with increasing prevalence and a substantial healthcare system burden. Globally, T2DM is the most common form of diabetes, accounting for approximately 90% of diabetes cases.1–3 According to the World Health Organization (WHO), approximately 830 million individuals globally have diabetes, and diabetes directly causes 1.6 million deaths yearly.4 The prevalence rate of diabetes, especially T2DM, is very high in the Kingdom of Saudi Arabia (KSA), and KSA has one of the highest T2DM prevalence rates. According to the International Diabetes Federation (IDF), Saudi Arabia has an adult diabetes prevalence rate of 17.7%, affecting approximately 4,274,100 individuals.5 This high T2DM prevalence results from rapid urbanization, Western lifestyle adoption, genetic predisposition, and changes in dietary habits, especially among the young population.3,6–8 Complications of T2DM include cardiovascular diseases, neuropathy, retinopathy, and nephropathy, and they worsen disability and mortality rates. In social terms, diabetes reduces productivity, limits activities of daily living, and affects mental health.9,10 Hence, a multi-pronged approach to reduce its effects, including prevention, early detection, patient education, lifestyle adjustments, and equitable healthcare, is required.9,11
Quality of life (QoL) is a multidimensional construct that uses a comprehensive approach to measure patients’ subjective well-being in different areas, including physical health, psychological state, social relations, and environmental factors12 Maintaining a good health-related quality of life (HRQoL) is essential in chronic conditions such as T2DM.13,14 HRQoL is focused on the impact of a disease and its treatment on an individual’s perception of health and general quality of life. T2DM severely affects the HRQoL because it is a chronic disease affecting multiple outcomes.
Wonde et al in 2022 demonstrated that approximately half of their study participants (patients with T2DM) had good HRQoL, and male sex, regular physical activity, and absence of complications were positively associated with HRQoL.15 Interestingly, Al-Shehri et al found that female patients had lower HRQoL than males.16 Lu et al conducted an HRQoL assessment survey in East China. They reported that patients with diabetes had lower HRQoL domain scores, significantly associated with age, sex, education status, and regional economic condition.17 Some authors assessed HRQoL among patients with T2DM using the EQ-5D, the WHOQOL-BREF, and the SF-36.18–20 These studies on the HRQoL of patients with T2DM were mainly performed in hospital settings or limited geographical regions using questionnaires that may not be applicable in primary care practice. The 20-item short-form health survey (SF-20) provides healthcare professionals with a validated, less time-consuming, and brief tool for measuring key HRQoL domains with reduced respondent time burden.19 AbuAlhommos et al surveyed adult patients with T2DM (≥ 18 years) in KSA using the EQ-5D-5L tool. This study was conducted at the Diabetic Centre at King Fahad Hospital and Prince Saud Bin Jalawy Hospital in the Al-Ahsa region of KSA. They reported that pain, mobility, and mental health were the commonly affected domains. Furthermore, their analysis found that being between 26 and 40 years old, being married, having a family history, and having good medication adherence were positively associated with a good quality of life.19
The available literature indicates that HRQoL varies across countries and regions.15,18,21,22 Conducting this study in the KSA is justifiable and brings several potential advantages that could promote our knowledge of HRQoL among patients with T2DM. First, the KSA has significant geographical, cultural, and socioeconomic diversity across its regions, which can affect the prevalence, risk factors, and outcomes of T2DM. Furthermore, predictors of HRQoL change over time. Globally, including in the KSA, primary health centers (PHCs) are the cornerstone of treating and following several chronic diseases, including T2DM. Therefore, it is essential to conduct the study in primary care settings. Additionally, continuous assessment of the profound influence of T2DM on HRQoL is essential to healthcare professionals and stakeholders because it helps them to customize interventions and support services that cover all aspects of patients’ lives.16,19,23 Hence, the present study aimed to assess HRQoL and associated factors among patients with T2DM from PHCs in the Aljouf province of the KSA to plan for policy-driven interventions and improve patient outcomes.
Materials and Methods
Study Description
The present survey used an analytical cross-sectional design. It was conducted from June 2024 to December 2024 in the Aljouf province of the KSA, which is in the northern part of the country. In the KSA, healthcare delivery, including diabetes management, is delivered through different levels, ranging from PHCs to specialized diabetes clinics. While urban regions such as Riyadh and Jeddah are equipped with advanced tertiary care services, northern provinces like Aljouf rely heavily on PHCs for chronic disease management, including diabetes care. The present study included Saudi adults (≥18 years) diagnosed with T2DM at least six months before the study who had completed at least one follow-up visit at the PHC. We excluded those with mental illnesses that could affect their ability to comprehend (such as major depressive disorder and cognitive impairment), those with physical disability (that significantly limited their mobility), pregnant women, those with other types of diabetes, hospitalized patients, those on only lifestyle management, and those who were unwilling to participate.
Sampling Procedures
The present survey utilized the WHO sample size calculator, which uses Cochran’s sample size estimation principles.24 Considering the expected variation in HRQoL across the regions, we used 50% as the expected proportion (p) to calculate the sample size. Other factors considered were a 5% margin of error, a 95% confidence interval, and an 80% power of the study. We applied all these values to the sample size calculator and obtained 384 as the minimum number of participants. The present study used a non-probability convenient sampling method to select the required participants. Initially, we selected 10 PHCs from all available centers across Aljouf province to ensure geographical representation. Within each center, eligible patients with T2DM were approached consecutively after their follow-up appointments, and participation was voluntary. To ensure adequate distribution over time and minimize selection bias, we limited enrollment to a maximum of five participants per center per day. Data collection was continued until the target sample size was reached.
Data Collection Steps
The authors conducted this study in accordance with the Declaration of Helsinki. First, we received the necessary ethical clearances from the authorities concerned (Riyadh Second Health Cluster, approval no:24–553E). Second, the authors obtained permission from other authorities to collect patient data. After briefing the participants about the study and obtaining informed consent, we asked the patients with T2DM to complete the survey on the data collectors’ devices through Google Forms. However, only the principal investigator could access the backend of the Google form to ensure data protection according to the ethical review board instructions. The authors collected only anonymous data; only the study’s overall findings are presented in the manuscript.
Data Collection Instrument
The authors used the validated SF-20-Arabic version to collect data from patients with T2DM and assess multiple health dimensions.25 This tool solves the problems that many researchers have with the length of their surveys. The tool was created to lessen the time load on respondents while maintaining the goal to be achieved, and it improves the response rate. SF-20 was initially developed in English by the RAND medical outcome study.25 The present study’s research team translated the survey questionnaire into Arabic, and the authors followed standard protocols to ensure accuracy and cultural relevance.25–27 The translation involved the following process: first, a bilingual translator whose native language is Arabic performed the forward translation, followed by a backward translation into English by an independent translator. Next, a panel of family medicine, public health, and internal medicine experts analyzed both versions to validate the translation process. They ensured that each item maintained the same meaning as the original English version. The translated questionnaire was tested using a pilot study (32 patients with T2DM) to check its adaptability to local settings, validity, and reliability. All pilot study participants provided input, indicating that the instrument was straightforward and easy to comprehend. Cronbach’s alpha values for all domains were greater than 0.70, indicating acceptable internal consistency and reliability for use in the target population. The questionnaire consisted of two sections. The first section gathered sociodemographic and health-related information, including age, sex, monthly income, and diabetes duration. The second section evaluated the HRQoL of participants using the SF-20-Arabic version. The SF-20 is a popular instrument for measuring HRQoL among patients with chronic conditions in research and clinical settings.25,28,29 The SF-20 assesses HRQoL across six predefined domains: physical functioning (six questions), role functioning (two questions), social functioning (one question), mental health (five questions), health perceptions (five questions), and pain (one question). Most items have multiple-choice response options, and the respondents choose the option that best describes their situation over a specific period, usually the last one or three months. Researchers can get an overview of an individual’s HRQoL, including all domains and individual domains. Each domain score is converted into 100%. Here, 0% indicates the lowest in that domain, and 100% indicates the highest score. The scoring is reversed when needed to ensure that the highest score always reflects the optimal score. Finally, we grouped each domain and overall HRQoL score into low (< 50% of total), medium (50 to 75% of total), and high (> 75% of total).
Data Analysis
The present study utilized the Statistical Package for Social Sciences version 24.0 (SPSS V.24) for data exporting, curation, and further analysis. Descriptive data are presented as frequencies, proportions, means, and standard deviations (SD). Initially, Shapiro–Wilk tests and Q-Q plots were used to assess the data for normality; however, the data were skewed. Hence, we applied Mann–Whitney U and Kruskal–Wallis tests for dichotomous and categorical variables, respectively, to each domain. Because non-parametric tests were performed, the mean rank and p-values were presented. Significantly higher mean ranks obtained from the Mann–Whitney U and Kruskal–Wallis tests indicate higher and better HRQoL. Finally, we performed a multivariate analysis to identify the sociodemographic and health-related factors associated with HRQoL. For the multivariate analysis, we used a binomial logistic regression analysis (enter method), where all selected independent variables were entered into the model simultaneously. We adjusted for age, sex, education, occupation, marital status, income, smoking, body mass index (BMI), follow-up, duration of diabetes, treatment type, and presence of chronic diseases in the model. We determined the confidence intervals (CIs) and adjusted odds ratios (AORs) using the logistic regression model. A p-value of less than 0.05 was considered statistically significant.
Results
The authors contacted 456 patients to get the required study participants, with a response rate of 85.5%. Of the 390 patients with T2DM, the majority (41.0%) were aged 46 to 60 years, males (55.6%), currently married (63.1%), working in private sectors (40.8%), non-smokers (64.9%), and within the normal BMI range (45.6%). Regarding their diabetes-related care, 66.7% were regularly being followed up at the health centers, and 69.7% were administered only oral hypoglycemic agents (OHAs) (Table 1).
![]() |
Table 1 Background and Health-Related Profiles of Type 2 Diabetes Mellitus (T2DM) Patients (n = 390) |
The descriptive data (mean, SD, median, and IQR [interquartile range]) of the six HRQoL domains are shown in Table 2. The role functioning domain had the highest mean score (75.7 ± 19.7), followed by physical functioning (71.9 ± 15.4) and health perception (57.5 ± 7.17) domains. The overall score was 53.2 ± 16.2.
![]() |
Table 2 Health-Related Quality of Life (HRQoL) Domains Evaluated by SF-20 |
The relationship between the characteristics of patients with T2DM and health perception, physical functioning, and pain domains is shown in Table 3. The health perception domain was significantly associated with sex (p = 0.007), education status (p = 0.001), marital status (p = 0.035), follow-up (p = 0.038), and smoking status (p = 0.014). The physical functioning domain was significantly associated with occupation (p = 0.042), marital status (p = 0.018), income (p = 0.001), and duration of diabetes (p = 0.005). We found that age (p = 0.002), occupation (p = 0.001), BMI (p = 0.021), and duration of diabetes (p = 0.012) were significantly associated with the pain domain. The type of treatment received by the T2DM patients was significantly associated with all three domains.
![]() |
Table 3 Relationship Between T2DM Patients’ Characteristics with Health Perception, Physical Functioning, and Pain Domains |
The relationship between patients’ characteristics and the role of functioning, social functioning, and mental health domains are presented in Table 4. Among the participants, the role of the functioning domain was significantly related to sex (p = 0.003), income (p = 0.001), smoking status (p = 0.027), follow-up (p = 0.007), treatment type (p = 0.007), and presence of other chronic diseases (p = 0.029). Age (p = 0.001), education status (p = 0.003), marital status (p = 0.004), and duration of diabetes (p = 0.038) were significantly associated with the social functioning domain. Additionally, the mental health domain was significantly related to sex (p = 0.001), education (p = 0.022), occupation (p = 0.017), monthly income (p = 0.042), and follow-up (p = 0.016).
![]() |
Table 4 Relationship Between T2DM Patients’ Characteristics with Role of Functioning, Social Functioning, and Mental Health Domains |
Based on the classification described earlier, the proportions of patients with high-level HRQoL varied across domains, being highest in the role of functioning domain (48.2%) and lowest in the health perception domain (16.6%). We found that 41% of the patients belonged to the high HRQoL category (Table 5).
![]() |
Table 5 Distribution of HRQoL Domain Scores by Category (n = 390) |
The binomial logistic regression analysis found that the overall HRQoL was significantly higher among those with the following characteristics: male (Reference [ref]: female; AOR = 2.66, 95% CI = 1.43–3.82, p = 0.002) and those on OHAs (ref: insulin; AOR = 5.18, 95% CI = 2.08–6.92, p = 0.002). A significantly lower level of HRQoL was observed among obese patients (ref: normal weight; AOR = 0.036, 95% CI = 0.79–0.93, p = 0.036), patients with irregular follow-up at the center (ref: regular follow-up; AOR = 0.58, 95% CI = 0.33–0.87, p = 0.004), and those with other chronic diseases (ref: no comorbidities; AOR = 0.64, 95% CI = 0.52–0.85, p = 0.006; Table 6).
![]() |
Table 6 Factors Associated with Overall HRQoL Among T2DM Patients. Test Applied: Binomial Logistic Regression Analysis |
Discussion
The present study assessed HRQoL and associated factors among patients with T2DM attending PHCs in the Aljouf region of the KSA using a validated data collection form. The health perception domain had a moderate mean score of about 57%, indicating that patients with T2DM generally perceived their health as average. Previous studies in KSA and other countries showed varying general health perceptions among study participants.19,22,30 For instance, Esubalew et al reported slightly higher mean general health perception scores among their study participants.22 Understanding the sociodemographic and health-related variables that significantly affect this domain is very important. The present study identified sex, education level, marital status, smoking habit, and regular follow-up at the PHCs as significant factors. Participants with a higher level of education and males had high health perception scores; this implies a better understanding of their challenges because diabetes education plays a significant role in diabetes care.18,31,32 For example, Homady et al found that HRQoL was significantly higher among patients with higher qualifications.18 Married patients obtained higher health perception values; such patients are believed to benefit from existing emotional and social support systems. Our findings are similar to those of some studies, which also reported low HRQoL among T2DM patients and contrast with those of others, where higher HRQoL scores were reported.22,33,34 The varying results across the studies are attributed to study settings, data collection tools used, and sociocultural factors such as family support and access to care.
The present study revealed a relatively higher mean score and a lesser proportion (14.5%) of low categories in the physical functioning domain. This finding suggests the effectiveness of existing diabetes care at the PHCs of the KSA. We found that physical functioning scores were lower among those with a long duration of T2DM, reflecting the progressive impact of the disease on physical abilities over time. Similar to the present study, Alshahrani et al in the KSA,35 Esubalew et al in Ethiopia,22 and Tusa et al in Sub-Saharan countries36 demonstrated the association between quality of life and disease duration. Moreover, currently, married participants have higher scores in this domain, which could be due to the practical support provided by partners, as previously discussed. Social functioning and pain domains had the lowest mean scores of the six domains. The low social functioning domain score indicates that the present study participants had challenges maintaining social relationships and engagement. The social functioning domain score was significantly lower among aged people and patients with a longer duration of diabetes. Additionally, these patients demonstrated lower pain domain scores; along with its significant association with a longer duration of disease, this finding is likely due to the development of chronic complications such as neuropathy and the cumulative disease burden associated with obesity and other chronic diseases.37–39 A recent study by AbuAlhommos et al reported that pain is one of the most affected domains. They also showed that not having pain is significantly associated with age, sex, duration of diabetes, and some other variables.19 Therefore, policymakers should consider the social challenges of the patients in addition to physical pain. Furthermore, incorporating pain management services, especially for high-risk patients with T2DM, such as the aged, patients with a higher BMI, and patients with a longer duration of disease, could be beneficial. The findings of this study have important implications for both primary healthcare practice and policy formulation in the KSA. Identifying specific domains with lower HRQoL—such as pain and social functioning—highlights the need for targeted and domain-specific interventions rather than a one-size-fits-all approach.
Our findings showed that role functioning recorded the highest mean score among all domains, indicating that most participants could manage their daily responsibilities effectively despite their condition. The higher scores among participants with higher incomes could be due to limited financial constraints that helped them perform daily tasks better. Moreover, regular follow-up and effective disease management reduce complications, thereby decreasing the financial burden. A recent study by Amin et al stated that higher family income positively correlated with the QoL of their study participants.40 Similarly, a systematic review by Teli et al also reported the relationship between income and HRQoL among adult patients with T2DM.41 Some authors evaluated different aspects of mental health and its association with T2DM, and they stated that mental illnesses are more common among patients with T2DM patients, especially those with uncontrolled blood sugar.42–44 In the present study, less than one-third of the participants belonged to the high category of the mental health domain. Additionally, the mean score of approximately fifty-one indicates mixed outcomes in terms of psychological well-being among participants. The present study revealed that patients who followed the physicians’ instructions had better mental health, demonstrating the importance of consistent healthcare interactions in providing reassurance and addressing emotional concerns.
Our study shows significant differences between HRQoL measures in patients with T2DM patients in primary healthcare and those in patients with pre-dialysis stage or end-stage renal disease (ESRD).45,46 The HRQoL of patients with chronic kidney disease (CKD) is low, particularly among people undergoing dialysis. Research has shown that patients with diabetes undergoing hemodialysis have worse HRQoL scores in the physical and mental dimensions than their non-diabetic counterparts. This indicates that early interventions for primary care patients with T2DM are of paramount importance because uncontrolled diabetes is a leading cause of renal failure. A recent study supports our finding, showing that HRQoL deteriorates with the progression of chronic diseases.47
Our study revealed that only 40% of the participants had a high overall HRQoL. This indicates room for improvement in managing the broader impacts of T2DM on quality of life. HRQoL was significantly higher among males and those administered OHAs. The better scores in OHA groups were attributed to numerous factors, including better adherence and ease of use compared to insulin therapy. The observed negative association of obesity with the overall HRQoL and its other domains may be due to several direct and indirect factors, including pathophysiological and psychological factors. Previous studies conducted in different settings have shown varying overall and domain scores. Similarly, the predictors of poor HRQoL also varied across settings.18,19,21,36 The variation across studies may be due to differences in socioeconomic conditions, availability and accessibility of healthcare services, and research methods. The significant associations with factors like obesity, comorbidities, and irregular follow-ups suggest that routine HRQoL assessments should be integrated into T2DM management protocols at the PHC level. These insights can inform future patient-centered care models, guide resource allocation, and shape health education programs.
The authors conducted this survey using a standard and validated instrument to reach a conclusion. To our knowledge, this is one of the first studies to use the Arabic SF-20 to assess the HRQoL among patients with T2DM in PHCs in the Aljouf region of the KSA. The study represents various locations, using a multi-site sample from ten PHCs and providing both statistical adequacy and practical value for primary care treatment. The research presents domain-specific HRQoL assessments, making it possible to develop more accurate clinical and policy solutions. The research results provide essential baseline information that can be used in designing future longitudinal or interventional studies. However, a few limitations should be noted while interpreting the study findings. First, as discussed earlier, the HRQoL life is influenced by numerous factors. Hence, the generalizability of this study’s findings is limited. Second, the data from patients with T2DM was self-reported, and the possibility of an exaggerated response and recall bias must not be overlooked. Next, this study did not include certain psychosocial and environmental factors that could influence the HRQoL. These unmeasured variables may have influenced the findings and should be considered in future mixed-method or longitudinal studies. Additionally, we did not collect laboratory data, which could have provided deeper insight into disease control and its impact on HRQoL. Finally, the present study was conducted in PHCs. Hence, excluding patients from other healthcare facilities, such as secondary or tertiary care hospitals, represents a limitation.
Conclusion
The present survey provides important insights into the HRQoL of patients with T2DM attending PHCs in the central KSA. The scores varied across HRQoL domains, with role functioning scoring the highest, and pain and social functioning identified as areas of concern. Furthermore, some characteristics, such as marital status, type of treatment, and follow-up adherence, were significantly associated with most domains and the overall HRQoL. Therefore, we recommend policy changes in primary healthcare protocols to integrate routine HRQoL assessments for patients with T2DM. The research results support the creation of new primary healthcare protocols to add standard HRQoL evaluations for patients with T2DM. Specific strategies should include structured patient education protocols and pain management centers at PHCs. Our study findings suggest implementing interventions that focus on high-risk patients with T2DM, including those with obesity, irregular follow-up adherence, and longer disease duration. These healthcare approaches should become part of established chronic disease management guidelines to offer holistic diabetes care. Furthermore, prospective follow-up of the impact of implemented programs on the HRQoL of patients with T2DM is necessary. Moreover, incorporating pain management specialty clinics into PHCs, especially for high-risk patients with T2DM, may be beneficial. Finally, we recommend performing multicentric mixed-method studies, which can provide deeper insights into the psychosocial, emotional, and cultural factors affecting HRQoL among patients with T2DM, aspects that are often not fully captured through quantitative tools alone.
Funding
This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University under grant No. (DGSSR-2024-01-01043).
Disclosure
The author(s) report no conflicts of interest in this work.
References
1. Babakhanian M, Razavi A, Rahimi Pordanjani S, Hassanabadi S, Mohammadi G, Fattah A. High incidence of type 1 diabetes, type 2 diabetes and gestational diabetes in Central Iran: a six years results from Semnan health cohort. Ann Med Surg. 2022;82:104749. doi:10.1016/j.amsu.2022.104749
2. CDC. Diabetes Quick Facts | basics | diabetes | CDC. Centers for Disease Control and Prevention. 2024. Available from: https://www.cdc.gov/diabetes/basics/quick-facts.html#:~:text=Diabetes%20Fast%20Facts,-Diabetes%20Fast%20Facts&text=Type%202%20diabetes%20accounts%20for,for%20approximately%205%2D10%25.
3. Ong KL, Stafford LK, McLaughlin SA, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. doi:10.1016/s0140-6736(23)01301-6
4. WHO. Diabetes. World Health Organization. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
5. IDF. Diabetes in Saudi Arabia. International Diabetes Federation. Available from: https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/saudi-arabia/.
6. Alwadeai KS, Alhammad SA. Prevalence of type 2 diabetes mellitus and related factors among the general adult population in Saudi Arabia between 2016–2022: a systematic review and meta-analysis of the cross-sectional studies. Medicine. 2023;102(24):e34021. doi:10.1097/MD.0000000000034021
7. Aljulifi MZ. Prevalence and reasons of increased type 2 diabetes in gulf cooperation council countries. Saudi Med J. 2021;42(5):481–490. doi:10.15537/smj.2021.42.5.20200676
8. Alqahtani B, Elnaggar RK, Alshehri MM, Khunti K, Alenazi A. National and regional prevalence rates of diabetes in Saudi Arabia: analysis of national survey data. Int J Diabetes Dev Countries. 2023;43(3):392–397. doi:10.1007/s13410-022-01092-1
9. Cuddapah GV, Vallivedu Chennakesavulu P, Pentapurthy P, et al. Complications in diabetes mellitus: social determinants and trends. Cureus. 2022;14(4):e24415. doi:10.7759/cureus.24415
10. Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the Type 2 Diabetes Mellitus. Curr Cardiol Rev. 2020;16(4):249–251. doi:10.2174/1573403x1604201229115531
11. Song Y, Zhu C, Shi B, et al. Social isolation, loneliness, and incident type 2 diabetes mellitus: results from two large prospective cohorts in Europe and East Asia and Mendelian randomization. EClinicalMedicine. 2023;64:102236. doi:10.1016/j.eclinm.2023.102236
12. Teoli D, Bhardwaj A. Quality of Life. StatPearls Publishing; 2024. StatPearls.
13. Wang Y, Wu Y, Chu H, Xu Z, Sun X, Fang H. Association between health-related quality of life and access to chronic disease management by primary care facilities in mainland China: a cross-sectional study. Int J Environ Res Public Health. 2023;20(5). doi:10.3390/ijerph20054288
14. Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the international quality of life assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283–298. doi:10.1023/b:qure.0000018472.46236.05
15. Wonde TE, Ayene TR, Moges NA, Bazezew Y. Health-related quality of life and associated factors among type 2 diabetic adult patients in Debre Markos Referral Hospital, Northwest Ethiopia. Heliyon. 2022;8(8):e10182. doi:10.1016/j.heliyon.2022.e10182
16. Al-Shehri AH, Taha AZ, Bahnassy AA, Salah M. Health-related quality of life in type 2 diabetic patients. Ann Saudi Med. 2008;28(5):352–360. doi:10.5144/0256-4947.2008.352
17. Lu Y, Wang N, Chen Y, et al. Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord. 2017;17(1):38. doi:10.1186/s12902-017-0187-1
18. Homady A, Albasheer O, Bajawi A, et al. Health-related quality of life among type 2 diabetes patients in Southern Province of Saudi Arabia using WHOQOL-BREF: a cross-section study. Curr Diabetes Rev. 2023;19(7):e211222212099. doi:10.2174/1573399819666221221160136
19. AbuAlhommos AK, Alturaifi AH, Al-Bin Hamdhah AM, Al-Ramadhan HH, Al Ali ZA, Al Nasser HJ. The health-related quality of life of patients with type 2 diabetes in Saudi Arabia. Patient Prefer Adherence. 2022;16:1233–1245. doi:10.2147/ppa.S353525
20. AlSadrah SA. Impaired quality of life and diabetic foot disease in Saudi patients with type 2 diabetes: a cross-sectional analysis. SAGE Open Med. 2019;7:2050312119832092. doi:10.1177/2050312119832092
21. Alshayban D, Joseph R. Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: a cross-sectional study. PLoS One. 2020;15(1):e0227573. doi:10.1371/journal.pone.0227573
22. Esubalew H, Belachew A, Seid Y, Wondmagegn H, Temesgen K, Ayele T. Health-related quality of life among type 2 diabetes mellitus patients using the 36-item short form health survey (SF-36) in Central Ethiopia: a multicenter study. Diabetes Metab Syndr Obes. 2024;17:1039–1049. doi:10.2147/dmso.S448950
23. Zheng S, He A, Yu Y, Jiang L, Liang J, Wang P. Research trends and hotspots of health-related quality of life: a bibliometric analysis from 2000 to 2019. Health Qual Life Outcomes. 2021;19(1):130. doi:10.1186/s12955-021-01767-z
24. Cochran WG. Sampling Techniques. john wiley & sons; 1977.
25. SF-20. 20-item short form survey from the RAND Medical Outcomes Study. 2024. Available from: https://www.rand.org/health-care/surveys_tools/mos/20-item-short-form.html.
26. Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth. 2017;11(Suppl 1):S80–s89. doi:10.4103/sja.SJA_203_17
27. Khalaila R. Translation of questionnaires into Arabic in cross-cultural research: techniques and equivalence issues. J Transcult Nurs. 2013;24(4):363–370. doi:10.1177/1043659613493440
28. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26(7):724–735. doi:10.1097/00005650-198807000-00007
29. Carver DJ, Chapman CA, Thomas VS, Stadnyk KJ, Rockwood K. Validity and reliability of the medical outcomes study short form-20 questionnaire as a measure of quality of life in elderly people living at home. Age Ageing. 1999;28(2):169–174. doi:10.1093/ageing/28.2.169
30. Patil S, Patil Y, Patil SK. Assessment of quality of life in type 2 diabetes mellitus patients using world health organization quality of life-BREF questionnaire and appraisal of diabetes scale-a cross-sectional study. Ital J Aerosp Med. 2021;15(3). doi:10.4081/itjm.2021.1444
31. Garg P, Duggal N. Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review. Obesity Med. 2022;35:100459. doi:10.1016/j.obmed.2022.100459
32. Mustapa A, Justine M, Manaf H. Effects of patient education on the quality of life of patients with type 2 diabetes mellitus: a scoping review. Malays Fam Physician. 2022;17(3):22–32. doi:10.51866/rv.208
33. Tadesse G, Abdulhalik W, Dessie Abebaw A. Health-related quality of life and its associated factors among adult patients with type II diabetes attending Mizan Tepi University Teaching Hospital, Southwest Ethiopia. BMJ Open Diabetes Res Care. 2019;7(1):e000577. doi:10.1136/bmjdrc-2018-000577
34. Tavakkoli L, Dehghan A. Compare the quality of life in type 2 diabetic patients with healthy individuals (application of WHOQOL-BREF). Zahedan J Res Med Sci. 2017;19(2):1–6.
35. Alshahrani JA, Alshahrani AS, Alshalaan AM, Alshahrani AM, Alhumam MN, NZt A. The impact of diabetes mellitus duration and complications on health-related quality of life among type 2 diabetic patients in Khamis Mushit City, Saudi Arabia. Cureus. 2023;15(8):e44216. doi:10.7759/cureus.44216
36. Tusa BS, Weldesenbet AB, Gemada AT, Merga BT, Regassa LD. Health related quality of life and associated factors among diabetes patients in sub-Saharan countries: a systemic review and meta-analysis. Health Qual Life Outcomes. 2021;19(1):31. doi:10.1186/s12955-020-01655-y
37. Naranjo C, Ortega-Jiménez P, Del Reguero L, Moratalla G, Failde I. Relationship between diabetic neuropathic pain and comorbidity. Their impact on pain intensity, diabetes complications and quality of life in patients with type-2 diabetes mellitus. Diabetes Res Clin Pract. 2020;165:108236. doi:10.1016/j.diabres.2020.108236
38. Degu H, Wondimagegnehu A, Yifru YM, Belachew A. Is health related quality of life influenced by diabetic neuropathic pain among type II diabetes mellitus patients in Ethiopia? PLoS One. 2019;14(2):e0211449. doi:10.1371/journal.pone.0211449
39. Dell’Isola A, Vinblad J, Turkiewicz A, et al. The coexistence of diabetes, hypertension and obesity is associated with worse pain outcomes following exercise for osteoarthritis: a cohort study on 80,893 patients. Osteoarthritis Cartilage. 2024;32(10):1308–1318. doi:10.1016/j.joca.2024.05.005
40. Amin MF, Bhowmik B, Rouf R, et al. Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh. BMC Endocr Disord. 2022;22(1):162. doi:10.1186/s12902-022-01072-w
41. Teli M, Thato R, Rias YA. Predicting factors of health-related quality of life among adults with type 2 diabetes: a systematic review. Sage Open Nurs. 2023;9:23779608231185921. doi:10.1177/23779608231185921
42. Thirunavukkarasu A, Alharbi MS, Salahuddin M, et al. Evaluation of oral health-related quality of life and its association with mental health status of patients with type 2 diabetes mellitus in the post-COVID-19 pandemic era: a study from Central Saudi Arabia. Front Public Health. 2023;11:1158979. doi:10.3389/fpubh.2023.1158979
43. Busili A, Kumar K, Kudrna L, Busaily I. The risk factors for mental health disorders in patients with type 2 diabetes: an umbrella review of systematic reviews with and without meta-analysis. Heliyon. 2024;10(7):e28782. doi:10.1016/j.heliyon.2024.e28782
44. Aljohani W, Algohani L, Alzahrani A, et al. Prevalence of depression among patients with type 2 diabetes at King Abdullah Medical City. Cureus. 2021;13(10):e18447. doi:10.7759/cureus.18447
45. Manju L, Joseph J. Health-related quality of life among patients undergoing hemodialysis in a tertiary center in South Kerala. Clin Epidemiol Global Health. 2024;26:101547. doi:10.1016/j.cegh.2024.101547
46. Dembowska E, Jaroń A, Gabrysz-Trybek E, Bladowska J, Gacek S, Trybek G. Quality of life in patients with end-stage renal disease undergoing hemodialysis. J Clin Med. 2022;11(6). doi:10.3390/jcm11061584
47. Neyazi A, Mohammadi AQ, Neyazi M, Timilsina S, Padhi BK, Griffiths MD. Hypertension, depression, and health-related quality of life among hospitalized patients in Afghanistan. J Human Hypertens. 2024;38(6):529–537. doi:10.1038/s41371-024-00914-5
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.